Medical publisher Mary Ann Liebert, Inc., US, has announced the launch of a bimonthly open access peer-reviewed journal, Shingles and PHN. Scheduled for launch in fall 2011, the journal will provide a much-needed authoritative source and central forum on research and clinical applications.
There are reportedly over 1 million new cases of shingles each year in the US alone. An outbreak of shingles is often followed by a disabling condition known as postherpetic neuralgia (PHN), which is difficult to treat and can have serious consequences. More than 1 in 3 people in the U.S. will develop shingles in their lifetime. Shingles is a painful skin rash caused by the varicella zoster virus, the same virus that causes chickenpox.
Shingles and PHN will explore all aspects of shingles and PHN, including studies of the virus; what causes the virus to reactivate; its actions on the human body; effective pharmacologic and nonpharmacologic acute treatment of shingles and long-term management of PHN; benefits and contraindications of the shingles vaccine; and implications for insurers and policymakers. The journal will include a broad range of scientific research and clinical studies with an impact across many fields including virology, epidemiology, infectious disease, neurology, dermatology, primary care, and policymakers to address this common and disabling condition.
The journal is under the editorial leadership of Dr. Barbara P. Yawn, Director of Research, Olmsted Medical Center, and Adjunct Professor, Family and Community Health, University of Minnesota. Dr. Yawn's research has provided some of the largest group of community-based shingles cases for which diagnosis has been confirmed by medical record review, and shingles complications have been explored.
Search for more Infectious Diseases related medical journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
